Using recombinant human G-CSF to treat chemotherapy-induced neutropenia over 3 decades: What is next?
<p>Chemotherapy-Induced Neutropenia (CIN) is a potentially fatal side effect of cancer treatment, affecting > 50% of cancer patients treated with chemotherapy. Clinical use of recombinant human granulocyte colony-stimulating factor (rhG-CSF) has allowed for primary and secondary prophylaxis...
Bewaard in:
Hoofdauteurs: | Jason Xu (Auteur), Jonathan Sussman (Auteur), Jessica Xu (Auteur), Xing Zhao (Auteur), Xiao Qiang Yan (Auteur) |
---|---|
Formaat: | Boek |
Gepubliceerd in: |
Annals of Bone Marrow Research - Peertechz Publications,
2023-09-12.
|
Onderwerpen: | |
Online toegang: | Connect to this object online. |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|
Gelijkaardige items
-
Expression of recombinant G-CSF receptor domains and their inhibitory role on G-CSF function
door: Hamid Bakherad, et al.
Gepubliceerd in: (2020) -
Bioassay of Recombinant Human Granulocyte Colony Stimulating Factor (rhG-CSF) for Neutropenia Treatment in Male Sprague Dawley Rats
door: Riyona Desvy Pratiwi, et al.
Gepubliceerd in: (2020) -
Cost-Effectiveness Analysis of PEG-rhG-CSF as Primary Prophylaxis to Chemotherapy-Induced Neutropenia in Women With Breast Cancer in China: Results Based on Real-World Data
door: Jie Zhao, et al.
Gepubliceerd in: (2022) -
Recombinant Ganoderma lucidum Immunomodulatory Protein Improves the Treatment for Chemotherapy-Induced Neutropenia
door: Xinhua Lei, et al.
Gepubliceerd in: (2020) -
Chemotherapy adjuvant and chemotherapy-induced neutropenia
door: Yiu-Tai Li, et al.
Gepubliceerd in: (2022)